Cassava Sciences, Inc.
(NASDAQ: SAVA)

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

2.380 -

+0.260 (+12.26%)
Range 2.190 - 2.490   (13.70%)
Open 2.190
Previous Close 2.120
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 2,089,957
Value 3,509,459
Remark -
Delayed prices. Updated at 11 Mar 2026 08:15.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis